메뉴 건너뛰기




Volumn 31, Issue 8, 2014, Pages 667-672

Palivizumab prophylaxis: Does it have any influence on the growth and development of the infants?

Author keywords

growth; neurodevelopment; palivizumab; rehospitalization; respiratory syncitial virus

Indexed keywords

PALIVIZUMAB; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY;

EID: 84904857008     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1356485     Document Type: Article
Times cited : (10)

References (11)
  • 1
    • 34848835483 scopus 로고    scopus 로고
    • Cost, causes and rates of rehospitalization of preterm infants
    • DOI 10.1038/sj.jp.7211801, PII 7211801
    • Underwood M. A., Danielsen B., Gilbert W. M. Cost, causes and rates of rehospitalization of preterm infants. J Perinatol: 2007; 27 10 614 619 (Pubitemid 47491471)
    • (2007) Journal of Perinatology , vol.27 , Issue.10 , pp. 614-619
    • Underwood, M.A.1    Danielsen, B.2    Gilbert, W.M.3
  • 2
    • 82955162720 scopus 로고    scopus 로고
    • Rehospitalization in the first 2 years of life in children born preterm
    • Ralser E., Mueller W., Haberland C., et al. Rehospitalization in the first 2 years of life in children born preterm. Acta Paediatr: 2012; 101 1 e1 e5
    • (2012) Acta Paediatr , vol.101 , Issue.1
    • Ralser, E.1    Mueller, W.2    Haberland, C.3
  • 3
    • 0031290144 scopus 로고    scopus 로고
    • Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: A 3-year follow-up
    • Nachman S. A., Navaie-Waliser M., Qureshi M. Z. Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: A 3-year follow-up. Pediatrics: 1997; 100 6 E8
    • (1997) Pediatrics , vol.100 , Issue.6
    • Nachman, S.A.1    Navaie-Waliser, M.2    Qureshi, M.Z.3
  • 4
    • 0031683919 scopus 로고    scopus 로고
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics: 1998; 102 3 Pt 1 531 537
    • (1998) Pediatrics , vol.102 , Issue.3 PART 1 , pp. 531-537
  • 5
    • 0031729747 scopus 로고    scopus 로고
    • Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV
    • American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn
    • American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics: 1998; 102 5 1211 1216
    • (1998) Pediatrics , vol.102 , Issue.5 , pp. 1211-1216
  • 6
    • 40949099150 scopus 로고    scopus 로고
    • A guide for monitoring child development in low- and middle-income countries
    • Ertem I. O., Doǧan D. G., Gök C. G., et al. A guide for monitoring child development in low- and middle-income countries. Pediatrics: 2008; 121 3 e581 e589
    • (2008) Pediatrics , vol.121 , Issue.3
    • Ertem, I.O.1    Doǧan, D.G.2    Gök, C.G.3
  • 8
    • 0037323548 scopus 로고    scopus 로고
    • Respiratory syncytial virus epidemics: The ups and downs of a seasonal virus
    • DOI 10.1097/00006454-200302001-00004
    • Stensballe L. G., Devasundaram J. K., Simoes E. A. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J: 2003; 22 (2, Suppl): S21 S32 (Pubitemid 36228149)
    • (2003) Pediatric Infectious Disease Journal , vol.22 , Issue.SUPPL. 2
    • Stensballe, L.G.1    Devasundaram, J.K.2    Simoes, E.A.F.3
  • 9
    • 28344445571 scopus 로고    scopus 로고
    • Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children
    • DOI 10.1016/j.vaccine.2005.02.004, PII S0264410X0500263X
    • Nicholson K. G., McNally T., Silverman M., Simons P., Stockton J. D., Zambon M. C. Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine: 2006; 24 1 102 108 (Pubitemid 41721106)
    • (2006) Vaccine , vol.24 , Issue.1 , pp. 102-108
    • Nicholson, K.G.1    McNally, T.2    Silverman, M.3    Simons, P.4    Stockton, J.D.5    Zambon, M.C.6
  • 10
    • 77956624960 scopus 로고    scopus 로고
    • Alt solunum yolu enfeksiyonu tanisiyla hastanemize yatirilan olgularda RSV enfeksiyonu sikliǧi ve klinik özellikleri. [The rate of RSV infection and their features in patients admitted to our hospital with a diagnosis of lower respiratory tract infection] (Turkish)
    • Hatipoǧlu S., Arica S., Çelik Y., et al. Alt solunum yolu enfeksiyonu tanisiyla hastanemize yatirilan olgularda RSV enfeksiyonu sikliǧi ve klinik özellikleri. [The rate of RSV infection and their features in patients admitted to our hospital with a diagnosis of lower respiratory tract infection] (Turkish). Düzce Tip Derg: 2009; 11 38 44
    • (2009) Düzce Tip Derg , vol.11 , pp. 38-44
    • Hatipoǧlu, S.1    Arica, S.2    Çelik, Y.3
  • 11
    • 0141682395 scopus 로고    scopus 로고
    • Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
    • DOI 10.1097/01.inf.0000086403.50417.7c
    • Pedraz C., Carbonell-Estrany X., Figueras-Aloy J., Quero J.; IRIS Study Group. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants. Pediatr Infect Dis J: 2003; 22 9 823 827 (Pubitemid 37153079)
    • (2003) Pediatric Infectious Disease Journal , vol.22 , Issue.9 , pp. 823-827
    • Pedraz, C.1    Carbonell-Estrany, X.2    Figueras-Aloy, J.3    Quero, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.